Vaccination program
What vaccine are you looking for?
Enter the name of a vaccine, disease, or destination to find the appropriate vaccine and get a complete fact sheet.
Frequent searches :
Flu
Zona
Children
Travel
Yellow fever
Meningitis
Hepatitis
COVID-19
Mpox
0 result(s) for « "
Indications - Why this vaccine?
What vaccination entails
Full directory
All our vaccines by category
Click on a category to see the details of each vaccine available at Clinique Omicron.
Children & Infants
Vaccination Schedule — From Birth to Adolescence
9 vaccines included
Diphtheria, Tetanus, Acellular Pertussis (DTaP)
Combined basic vaccination, administered from 2 months of age. Boosters at 4, 6, 18 months, and 4–6 years. Included in pediatric combination vaccines.
Polio (IPV)
Inactivated vaccine against the 3 serotypes of poliovirus. Included in combination vaccines. Lifelong protection after complete series.
Haemophilus influenzae type b (Hib)
Prevents serious bacterial meningitis and pneumonia in children under 5 years old. Included in combination vaccines.
Pneumococcal conjugate (PCV13/PCV15/PCV20)
Protection against pneumococcal meningitis, pneumonia, and otitis. 3-4 doses in infants. 1 dose for at-risk adults.
Measles, Mumps, Rubella (MMR)
Combined live attenuated vaccine. 2 doses: 12 months and 18 months. Also recommended for unvaccinated adults.
Chickenpox (Varivax® / Varilrix®)
Live attenuated vaccine. 1 dose at 18 months. Also reduces the risk of shingles in adulthood.
Hepatitis B (Engerix-B® / Recombivax®)
3 doses in infants (2, 4, 6 months). Available separately for adults. Recommended for healthcare workers.
Rotavirus (Rotarix® / RotaTeq® — oral)
Live attenuated oral vaccine against severe gastroenteritis. Administered before 8 months of age. Highly effective in preventing hospitalizations.
Meningococcal C conjugate (Menjugate® / Neis Vac-C®)
Protection against *Neisseria meningitidis* serogroup C. 2 doses: 12 and 18 months. Booster dose recommended in adolescence.
Adults & 50+
Adult Vaccination — Boosters, Prevention, and New Vaccines
9 vaccines included
Influenza (seasonal flu)
Annual vaccine adapted to circulating strains. Fluad® high dose for those 65 and older. Available in clinic and at home starting in October.
Shingrix
Efficacy >90%%. 2 doses (0 and 2–6 months). Non-live, can be administered to immunocompromised individuals. Recommended for all 50 years and older.
Pneumococcal Polysaccharide Vaccine (PPSV23 / Pneumovax®)
Protection against 23 pneumococcal serotypes. Recommended for individuals 65 years and older and adults with chronic diseases or asplenia.
COVID-19 (Boosters — Comirnaty® / Spikevax®)
mRNA boosters adapted to circulating variants. 1 annual dose for people 60 and over and high-risk individuals.
Tdap adult booster (Adacel® / Boostrix®)
Diphtheria, tetanus, and acellular pertussis booster shot. Every 10 years, or after a tetanus-prone injury. Available at home.
HPV - Human Papillomavirus (Gardasil 9®)
Protection against 9 HPV genotypes. 2 doses (9–14 years old) or 3 doses (15–45 years old). Prevents anogenital cancers and genital warts.
RSV - Respiratory Syncytial Virus (Abrysvo® / mRESVIA®)
New vaccine for those 60 and older against RSV. 1 single dose. Protection for 2+ seasons. Available in clinics and at home.
Meningococcal B (Bexsero® / Trumenba®)
Protection against meningococcal serogroup B. Recommended for adolescents in university residences and at-risk individuals. 2–3 doses.
Mpox — Monkeypox (Imvamune®)
Third-generation non-replicating vaccine recommended by the PIQ for individuals at high risk (MSM with multiple partners, sex workers, exposure in outbreak settings). 2 doses 28 days apart.
Travel & Specialty
Travel Health — Designated Yellow Fever Center (DYFC)
11 vaccines included
Yellow fever (Stamaril®) — Official CIVP Center
1 single lifetime dose (WHO 2016). Official ICVP issued on-site. Administration reserved for designated centers by Health Canada According to the International Health Regulations. Mandatory for certain countries in Africa and South America. Travel consultation included.
Hepatitis A (Havrix® / Avaxim®)
Protection against Hepatitis A transmitted by contaminated water and food. 2 doses. Recommended for Asia, Africa, Latin America.
Hepatitis A + B combined (Twinrix®)
Simultaneous protection against Hepatitis A and B in 3 doses. Accelerated schedule available if departure is imminent.
Injectable Typhoid (Typhim Vi® / Typherix®)
1 injection against Salmonella Typhi. Protection in 2 weeks. Booster at 3 years. Recommended for South Asia, Africa, Latin America.
Oral Typhoid (Vivotif® — capsules)
Oral alternative in 4 capsules over 7 days. 5-year protection. Keep refrigerated.
Typhoid + Hepatitis A combined (Vivaxim®)
1 injection combining typhoid and hepatitis A. Simplify the schedule for travelers. HepA booster at 6-12 months.
Meningococcal ACYW135 (Menactra® / Menveo®)
Mandatory for Hajj/Umrah. Recommended for Sub-Saharan Africa. Single dose valid for entry visa to Saudi Arabia.
Rabies — pre-exposure (Rabavert® / Imovax®)
3 doses for travelers at risk in rural areas of Asia, Africa, and Latin America. Significantly simplifies post-bite treatment.
Japanese encephalitis (Ixiaro®)
2 doses (0 and 28 days). Recommended for stays longer than 1 month in rural areas of Southeast Asia. Series to be completed 1 week before arrival.
Tick-borne encephalitis (FSME-Immun® / Encepur®)
For hikers in forests of Central and Eastern Europe. 3 standard doses or accelerated schedule. Boosters every 3–5 years.
Cholera / ETEC — Traveler's Diarrhea (Dukoral® — oral)
2 oral doses, 1 week apart. Protection against cholera (2 years) and traveler's diarrhea caused by E. coli (3 months).
All vaccines are administered in accordance with the Quebec Immunization Protocol (QIP) by healthcare professionals who are members of their professional order. Availability may vary by branch. For malaria vaccination, no vaccine is available—however, we offer a travel medical consultation with a prescription for preventive medication.